Journal of affective disorders Journal

Overview
Identity
View All

publication venue for

Association between cognitive functioning, suicidal ideation and suicide attempts in major depressive disorder, bipolar disorder, schizophrenia and related disorders: A systematic review and meta-analysis.. 381-399. 2024
A replication study using the World Health Organization pharmacovigilance database (VigiBase®) to evaluate whether an association between ketamine and esketamine and alcohol and substance misuse exists.. 589-594. 2024
Preclinical and clinical efficacy of kappa opioid receptor antagonists for depression: A systematic review.. 816-827. 2024
Comparing suicide completion rates in bipolar I versus bipolar II disorder: A systematic review and meta-analysis.. 480-488. 2024
The role of KCNQ channel activators in management of major depressive disorder.. 364-372. 2024
National trends and correlates of treatment resistance in major depressive episode and associated suicidal ideation and behaviors among adults in the United States.. 342-349. 2024
Effects of anhedonia on health-related quality of life and functional outcomes in major depressive disorder: A systematic review and meta-analysis.. 684-698. 2024
Number needed to treat (NNT) for ketamine and esketamine in adults with treatment-resistant depression: A systematic review and meta-analysis.. 753-762. 2024
Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic review.. 342-354. 2024
The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data.. 314-322. 2023
Is psychiatric diagnostic remission associated with reduced prevalence of moderate to severe pain interference and improved functioning among adults with lifetime psychiatric disorders?. 585-591. 2023
Clinical efficacy and safety of Zuranolone (SAGE-217) in individuals with major depressive disorder.. 893-898. 2023
Biomarkers of ketamine's antidepressant effect: An umbrella review.. 598-606. 2022
Association of current and remitted bipolar disorders with health-related quality of life: Findings from a nationally representative sample in the US.. 33-40. 2022
Long-term depressive symptoms and midlife brain age.. 436-441. 2022
Trends in major depressive episodes and mental health treatment among older adults in the United States, 2010-2019.. 299-303. 2022
Impact of Tai Chi as an adjunct treatment on brain connectivity in geriatric depression.. 1-6. 2022
Why are women more likely to attempt suicide than men? Analysis of lifetime suicide attempts among US adults in a nationally representative sample.. 157-164. 2022
Prevalence of type 2 diabetes mellitus, impaired fasting glucose, general obesity, and abdominal obesity in patients with bipolar disorder: A systematic review and meta-analysis.. 449-461. 2021
Mechanisms of change in depression and anxiety within a mind-body activity intervention for chronic pain.. 534-541. 2021
The intersection of implementation science and community-based suicide prevention research: Opportunities to advance the field.. 237-239. 2021
Recovery from past suicide attempts: Correlates of time since the last attempt in a national sample of US adults.. 98-105. 2020
Stages of major depressive disorder and behavioral multi-morbidities: Findings from nationally representative epidemiologic study.. 443-452. 2020
Long-term outcome in outpatients with depression treated with acute and maintenance intravenous ketamine: A retrospective chart review.. 660-666. 2020
Network structures and temporal stability of self- and informant-rated affective symptoms in Alzheimer's disease.. 1084-1092. 2020
Longer-term open-label study of adjunctive riluzole in treatment-resistant depression.. 102-108. 2019
Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders.. 450-457. 2019
Inaccuracy between subjective reports and objective measures of sleep duration and clinical correlates in bipolar disorder.. 226-230. 2019
The impact of prolonged exposure therapy on social support and PTSD symptoms.. 410-417. 2019
Use of mental health services by community-resident adults with DSM-IV anxiety and mood disorders in a violence-prone area: São Paulo, Brazil.. 145-152. 2019
Familial and social transmission of suicidal behavior in older adults.. 589-596. 2018
GWAS and systems biology analysis of depressive symptoms among smokers from the COPDGene cohort.. 16-22. 2018
12-month prevalence and concomitants of DSM-IV depression and anxiety disorders in two violence-prone cities in Brazil.. 204-211. 2018
12-month trajectories of depressive symptoms among nurses-Contribution of personality, job characteristics, coping, and burnout.. 67-73. 2018
Severity of anxiety- but not depression- is associated with oxidative stress in Major Depressive Disorder.. 193-200. 2017
Therapeutic relationship in the treatment of geriatric depression with executive dysfunction.. 130-137. 2017
Exploring the excess mortality due to depressive symptoms in a community-based sample: The role of Alzheimer's Disease.. 163-70. 2016
The association of an inability to form and maintain close relationships due to a medical condition with anxiety and depressive disorders.. 130-6. 2016
Mood disorder symptoms and elevated cardiovascular disease risk in patients with bipolar disorder.. 138:405-8. 2012
Under-treatment of depression in older persons.. 136:789-96. 2011